Immunoassays • Snibe Diagnostic
Maglumi SARS-CoV-2 Neutralizing Antibody (CLIA)

Highlights:
Addressing the urgent need of assessing immunity during the COVID-19 pandemic
- An important tool of the COVID-19 vaccine efficacy assessment
- Evaluating immunity in individuals and community to provide immunity “certification” for returning to society
- Cost-effective and large-scale solution for neutralizing antibody test
- Highly sensitive and specific detection of neutralizing antibodies: 100 percent positive agreement to gold standard